Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Dr. Michael Keating, Founder, CLL Global Research Foundation
Dr. William Wierda, President & CEO, CLL Global Research Foundation
Dr. Alessandra Ferrajoli, Associate Medical Director, Department of Leukemia, MD Anderson Cancer Center
Jeff Folloder, Moderator and CLL patient advocate
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
This video is an excerpt from CLL Global Research Foundation’s October 2025 Virtual Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Catherine Wu of Dana-Farber Cancer Institute.
